◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 0574

Pa Shun International Holdings Limited (0574) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Pharmaceutical Retailers · DATA UPDATED 2026-08-10

Pa Shun International Holdings Limited (0574) operates in the Pharmaceutical Retailers industry and is headquartered in Wan Chai, Hong Kong with about 108 employees. Its market capitalization is roughly CNY 36 million. In the fiscal year ended 2025-12-31, 0574 reported CNY 87M in revenue and (CNY 16M) in net income.

Pa Shun International Holdings Limited, an investment holding company, engages in the pharmaceutical distribution and manufacturing businesses in the People's Republic of China. The company sells pharmaceutical products to wholesalers, hospitals, and other medical institutions in rural areas.

Interactive charts & full statements →

0574 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueCNY 87MCNY 87MCNY 129MCNY 72M
Gross ProfitCNY 12MCNY 17MCNY 29MCNY 13M
Operating Income (EBIT)CNY 4M(CNY 6M)CNY 22M(CNY 5M)
Net Income(CNY 16M)(CNY 15M)CNY 2M(CNY 43M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0574 Free Cash Flow History

0574 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsCNY 170MCNY 180MCNY 207MCNY 136M
Total LiabilitiesCNY 318MCNY 316MCNY 323MCNY 252M

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0574 viewer.

Other Companies in Pharmaceutical Retailers

← 0573All “0-9” companies0575 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.